Literature DB >> 11038423

Can CD34 discriminate between benign and malignant hepatocytic lesions in fine-needle aspirates and thin core biopsies?

W B de Boer1, A Segal, F A Frost, G F Sterrett.   

Abstract

BACKGROUND: Distinguishing well differentiated hepatocellular carcinoma (HCC) from benign hepatocellular lesions is a well recognized problem in fine-needle aspiration (FNA) cytology. The endothelial cell marker CD34 is negative in normal hepatic sinusoids and stains vessels diffusely in HCC. This feature is useful in distinguishing benign from malignant hepatocytic lesions in histological specimens, although benign lesions may show focal positivity for CD34 confined to periportal and periseptal areas. In this study, we assess the role of CD34 in cell block and thin core biopsy material from benign and malignant hepatocellular lesions, and compare it with reticulin staining.
METHODS: Cell blocks and thin core biopsies were assessed from 40 cases of HCC and 25 benign hepatocytic lesions. HCCs were scored for nuclear grade. Sections were stained for CD34 antigen and scored semi-quantitatively. Previously performed reticulin stains were reviewed.
RESULTS: Thirty three of 40 HCCs (82.5%) showed diffuse positivity for CD34. The other seven cases showed either focal positivity (four cases), minimal positivity (two cases) or negative staining (one case). These results did not correlate with the nuclear grade of the tumor. Two of 25 benign cases (8%) showed diffuse positivity for CD34, 8 showed focal positivity, 11 showed minimal positivity, and 4 showed negative staining. All HCCs showed an abnormal reticulin pattern characterized by expanded trabeculae and islands, or sheets, with decreased or absent reticulin. All of the benign hepatocellular lesions showed a normal trabecular reticulin pattern.
CONCLUSIONS: Diffusely positive CD34 staining is useful to support a diagnosis of well differentiated HCC, but in our study the reticulin stain distinguished more consistently between benign and malignant lesions.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11038423

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  11 in total

1.  Surveillance and diagnosis of hepatocellular carcinoma in patients with cirrhosis.

Authors:  Lorenzo Andreana; Graziella Isgrò; Maria Pleguezuelo; Giacomo Germani; Andrew K Burroughs
Journal:  World J Hepatol       Date:  2009-10-31

2.  Sub-chronic exposure to Kalach 360 SL-induced damage in rats' liver and hematological system.

Authors:  Latifa Hamdaoui; Manel Naifar; Fatma Rahmouni; Fatma Ayadi; Tarek Rebai
Journal:  Environ Sci Pollut Res Int       Date:  2019-11-16       Impact factor: 4.223

3.  Diagnostic value of immunohistochemical staining of GP73, GPC3, DCP, CD34, CD31, and reticulin staining in hepatocellular carcinoma.

Authors:  Shuzhe Yao; Jianping Zhang; Haiyan Chen; Yan Sheng; Xiaoying Zhang; Zhiyan Liu; Cuijuan Zhang
Journal:  J Histochem Cytochem       Date:  2013-05-16       Impact factor: 2.479

4.  Microvessel density of malignant and benign hepatic lesions and MRI evaluation.

Authors:  Jian-Ping Lu; Jian Wang; Tao Wang; Yi Wang; Wei-Qing Wu; Li Gao
Journal:  World J Gastroenterol       Date:  2004-06-15       Impact factor: 5.742

5.  Unusual reticulin staining pattern in well-differentiated hepatocellular carcinoma.

Authors:  Heng Hong; Bryan Patonay; James Finley
Journal:  Diagn Pathol       Date:  2011-02-22       Impact factor: 2.644

6.  Fine needle aspiration biopsy of the liver: Algorithmic approach and current issues in the diagnosis of hepatocellular carcinoma.

Authors:  Aileen Wee
Journal:  Cytojournal       Date:  2005-06-08       Impact factor: 2.091

Review 7.  Architectural aspects of cell-blocks as small biopsies.

Authors:  Swati Satturwar; Liron Pantanowitz
Journal:  Cytojournal       Date:  2021-03-04       Impact factor: 2.091

8.  Fine needle aspiration biopsy of liver - an update.

Authors:  David C Chhieng
Journal:  World J Surg Oncol       Date:  2004-03-16       Impact factor: 2.754

9.  Significance of overexpression of alpha methylacyl-coenzyme A racemase in hepatocellular carcinoma.

Authors:  Wei Li; Philip T Cagle; Rafael C Botero; John J Liang; Zhaoping Zhang; Dongfeng Tan
Journal:  J Exp Clin Cancer Res       Date:  2008-05-15

10.  Role of FNA and Core Biopsy of Primary and Metastatic Liver Disease.

Authors:  John P McGahan; John Bishop; John Webb; Lydia Howell; Natalie Torok; Ramit Lamba; Michael T Corwin
Journal:  Int J Hepatol       Date:  2013-11-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.